San Francisco, California
London, United Kingdom
Leonard Wolfson Experimental Neurology Centre
15th September 2014, 5 pm to 6 pm [followed by a wine reception]
Lecture Theatre, The National Hospital for Neurology and Neurosurgery,
33 Queen Square London WC1N 3BG
About the Event:
To celebrate the opening of the LWENC Clinical Facility and to promote its use among the UCL research community and with external academics, organisers (Professor John Hardy, Professor Nick Fox, Professor Mike Hanna and Dr Vincenzo Libri) are hosting an open event to highlight how the centre operates and the type of support it can offer to investigators.
The event will also represent an opportunity for attendees to hear more about the entire Wolfson Experimental Neurology programme at the Institute of Neurology, which includes the biomarker, imaging and PhD education programmes in neurodegeneration research, and the progress it has been making.
The meeting agenda is still being finalised and it will be made available in August.
Background Info on the Centre:
The new Leonard Wolfson Experimental Neurology Centre (LWENC) Clinical Research Facility within the NHNN is dedicated to experimental medicine and early phase clinical trials (including first-in-man studies) in healthy volunteers and patients across neurodegenerative diseases.
The Facility is designed to provide purpose-built, dedicated clinical and operational support to the whole research community at IoN and the NHNN. It opened to clinical activities in March 2014 and has adopted twenty-five studies to date.
For more information on the LWENC Open Evening please contact Dr Rajeshree Khengar, Clinical Projects Lead/Senior Operational Manager
When & Where
UCL is Europe’s research powerhouse in neuroscience. We are ranked second in the world, and first in Europe, in neuroscience and behaviour by Thomson ISI Essential Science Indicators, with more than twice as many publications and citations as any other European institution.
UCL Neuroscience researchers generate over 30% of the country’s contribution to the most highly cited publications in neuroscience, more than twice as much as any other university.
In neuroimaging and clinical neurology, UCL produces 65% and 44% of the UK's contribution to the world's most highly cited papers, five-fold larger than that of the next highest UK institution. The UCL Neuroscience Domain brings together over 450 principal investigators who conduct this world-leading work in seven themes that reflect the strength of neuroscience at UCL.